Biomedical NGS sequencing laboratory banner

Precision, Accuracy, and Quality

CD Genomics is committed to Push the Boundaries of Biomedical Engineering. Let our Biomedical NGS Platform Pave the Way from Biomarker Discovery to Project Deployment.

Choose Your Biomedical NGS Solutions

Immuno-oncology NGS sequencing solutions icon

Immuno-Oncology Solutions

Our BCR/TCR sequencing, HLA typing sequencing and cancer panel sequencing solutions can assist in the analysis of the tumor microenvironment, providing services for the development of disease mechanisms and therapeutic modalities for immuno-oncology.

View Immuno-Oncology Solutions

Genome editing and engineering NGS solutions icon

Genome Editing and Engineering Solutions

CD Genomics offers NGS-based CRISPR/Cas9 screening, validation sequencing and CRISPR off-target discovery solutions. Our gene editing solutions enable the screening and identification of variant genes at any genomic scale, advancing the development of gene editing technology.

View Genome Editing Solutions

Biomarker Discovery Solutions

Our NGS-based whole exome sequencing, target region sequencing and whole genome sequencing services make up the biomarker discovery solution. The discovery of new biomarkers gives new directions for the prediction and treatment of diseases.

View Biomarker Discovery Solutions

Viral vector development NGS solutions icon

Viral Vector Development Solutions

CD Genomics' viral vector development solutions primarily consist of lentiviral/retroviral integration site analysis and AAV sequencing services, which drive the discovery of viral vector development targets and the translational application of recombinant AAV vectors in viral vector development.

View Viral Vector Solutions

Pharma Research Solutions

In the pharmaceutical area, CD Genomics is able to offer a range of genome sequencing services that can be applied to the development of new drugs and the advancement of precision therapies.

View Pharma Research Solutions

Antibody Discovery Solutions

Antibody discovery is important for early research, diagnosis and treatment. Here, CD Genomics offers a high-throughput NGS-based antibody discovery platform that greatly improves the efficiency of antibody discovery.

View Antibody Discovery Solutions

eccDNA Research Solutions

By combining advanced sequencing technologies and bioinformatic analysis, we provide customized solutions to our clients to help them gain a deeper understanding of eccDNA-driven cancer mechanisms and therapeutic approaches.

View eccDNA Research Solutions

Featured NGS Sequencing Services

BCR and TCR Sequencing

HLA Typing

Cancer Panel Sequencing

DRUG-seq Service

Epigenome Sequencing

eccDNA Sequencing (Circle-Seq)

CRISPR Screening Sequencing

CRISPR Validation Sequencing

CRISPR Off-target Discovery

Lentiviral Integration Sites Analysis

AAV Sequencing

CRISPR Off-Target Validation Sequencing

Partnerships

CD Genomics genomics services laboratory team

Explore CD Genomics

CD Genomics is a world-leading genomics services company that aims to provide highly optimized NGS solutions to help industrial customers achieve optimal cost effectiveness. Our range of mainstream NGS sequencing facilities and technologies greatly expands our service offering. We are constantly striving to create innovative NGS-based solutions to meet your needs in fields related to immuno-oncology, disease research and drug discovery.

About Us

Welcome to your biomedical research center

CD Genomics is committed to being your first choice of partner. If you have any questions regarding our NGS solutions please feel free to contact us.